Skip to content

AI Symposium Session Summary: Is AI in clinical trials delivering measurable ROI?

Date: August 12, 2025

At the 4th Annual ACDM Symposium on Artificial Intelligence (AI) in Clinical Trials, the session “Overcoming AI Hype for Realised ROI: Taking a Problem-Centred Approach to Enterprise Transformation” confronted this challenge head-on.

Led by Jason Housley (eClinical Solutions), the discussion pulled no punches on why stubborn timelines persist despite decades of “next-gen” innovation – from blockchain to wearables to today’s AI.

Drawing on industry survey data, real-world case studies, and his “Golden Rules” for sustainable transformation, Jason shared how organisations can cut through the buzz and focus on the problems that truly matter – delivering tangible, measurable results rather than symbolic go-lives.

Read the session summary for key takeaways – pragmatic, experience-based, and laser-focused on turning AI potential into real ROI.

Click here to read

 

 


 

Explore More News

Regulatory Considerations Expert Group reviews draft FDA Guidance

The ACDM Regulatory Considerations Expert Group have reviewed and submitted comments on . . .

Read More

ICH GCP E6 Revision 3 is here. Regulatory Considerations Expert Group to review

The R&D industry, especially those that are working on clinical trials, have been . . .

Read More

Welcome Algorics as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome Algorics as a . . .

Read More

Consultation response on legislative proposals for clinical trials

The MHRA have published the public consultation response to the proposals to reform the . . .

Read More

New MHRA Guidance

The MHRA have published new guidance on ‘Software and Artificial Intelligence (AI) as a . . .

Read More

FDA Guidance for Industry 

The FDA has issued a final guidance to provide information on risk-based approaches to . . .

Read More

Guideline on computerised systems and electronic data in clinical trials

The European Medicines Agency (EMA) have published the new guidelines on computerised . . .

Read More

Welcome IROS – Insights Research Organization & Solutions as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome IROS – Insights . . .

Read More

Recommendation paper on decentralised elements in clinical trials

Following their meeting on 4 Oct, the EMA/HTAs and EC have published a recommendation . . .

Read More

Welcome George Clinical as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome George Clinical . . .

Read More

Welcome Clinion as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome Clinion as a . . .

Read More

Welcome ClinoSol Research as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome ClinoSol . . .

Read More